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Abstract
The size and concentration of exhaled particles may influence respiratory
infection transmission risk. We assessed variation in exhaled particle
production between individuals, factors associated with high production and
stability over time.
We measured exhaled particle production during tidal breathing in a sample of
79 healthy volunteers, using optical particle counter technology. Repeat
measurements (several months after baseline) were obtained for 37 of the 79
participants.   Multilevel linear regression models of log transformed particle
production measures were used to assess risk factors for high production.
 Stability between measurements over time was assessed using Lin’s
correlation coefficients.
Ninety-nine percent of expired particles were <1μm in diameter. Considerable
variation in exhaled particle production was observed between individuals and
within individuals over time. Distribution of particle production was right
skewed.  Approximately 90% of individuals produce <150 particles per litre in
normal breathing.  A few individuals had measurements of over 1000 particles
per litre (maximum 1456). Particle production increased with age (p<0.001) and
was associated with high tree pollen counts. Particle production levels did not
remain stable over time [rho 0.14 (95%CI -0.10, 0.38, p=0.238)].
Sub-micron particles conducive to airborne rather than droplet transmission
form the great majority of exhaled particles in tidal breathing. There is a high
level of variability between subjects but measurements are not stable over time.
Production increases with age and may be influenced by airway inflammation
caused by environmental irritants. Further research is needed to determine
whether the observed variations in exhaled particle production affect
transmission of respiratory infection.
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Introduction 
Exhaled particles serve as a vehicle of transmission for some patho-
gens. Respiratory infection transmission can be described as either 
droplet or airborne. Droplet transmission relates to larger particles 
that are expelled and rapidly settle to the ground, usually within 
1 minute of production1. Droplet transmission therefore relies on 
relatively close proximity to the source case. These larger particles 
are generated from the upper respiratory tract during coughing or 
sneezing or during procedures such as suctioning or bronchoscopy2. 
Larger particles tend to deposit on external mucus membranes or 
high up in the respiratory tract. Settled droplets can also contribute 
to fomite transmission. Airborne transmission is caused by smaller 
expelled particles which can stay suspended in the air for long 
periods exposing a greater number of contacts at greater distance1–3. 
They are formed by the re-opening of closed airway passages, 
which de-stabilise the mucous surface layer4. These smaller par-
ticles penetrate further into the lower respiratory tract to alveo-
lar level. It is not possible to define a cut-off particle diameter at 
which aerodynamic behaviour changes, however, the World Health 
Organisation use a 5 µm cut-off to distinguish between airborne and 
droplet transmission5. 
Recently, the development of optical particle counter (OPC) tech-
nology has enabled researchers to measure both the density and the 
full spectrum of sizes of expired droplets, from the submicron level 
to larger droplets6,7. Studies using that technology have demonstrat-
ed that the majority of particles produced during normal breathing 
and talking are of submicron size. Although coughing and sneez-
ing can produce 5 times more particles than normal breathing7, the 
latter accounts for the majority of expired bio-aerosols over the 
course of a day4,7–9. In addition, recent studies have shown that 
submicron particles exhaled during normal breathing can contain 
respiratory viruses6,10,11, suggesting that submicron particles could 
contribute to infectious disease transmission. The relative contribu-
tions of droplet and airborne transmission to the spread of different 
infections remains controversial but there is increasing recognition 
that airborne spread may be more important than previously thought 
for the transmission of respiratory viruses such as influenza12–17. 
For tuberculosis for example, airborne transmission is regarded as 
obligatory as mycobacteria need to reach alveolar levels to be taken 
up by macrophages18.
Early mathematical models of the spread of infectious diseases have 
tended to assume that infected individuals were largely homogenous 
within their age group with respect to transmission19,20. More recent 
modelling work shows substantial heterogeneity in transmission of 
SARS, measles, monkey pox and pneumonic plague21 suggesting 
the occurrence of “super-spreaders” of respiratory infections. Previ-
ous small-scale studies of exhaled particle production suggest that 
two distinct populations of particle producers exist: the majority 
of individuals are low producers (exhaling an average of less than 
500 particles per litre during normal breathing) and a few are high 
producers (producing more than 500 particles per litre)4,7. It has 
been hypothesised that high level producers of exhaled particles (so-
called “super-producers”) may be “super-spreaders” of respiratory 
infection. To date published studies of exhaled particle production 
have included small numbers of individuals, limiting the ability to 
describe the range of particle production and factors associated with 
high production and have not examined the long-term stability of 
exhaled particle production within individuals. For example one study 
with 16 volunteers22 examined the stability of exhaled particles only 
over the course of 2 months.
This study aimed to explore the characteristics of exhaled particle 
production in healthy individuals, its stability over time, and factors 
associated with high levels of particle production. Findings from 
this study may have implications for theories and models of infec-
tious disease transmission through the respiratory route.
Methods for data collection
Ethical approval for this study was received by University College 
London Ethics Committee (Reference number 1564/001). We 
collected data from a convenience sample of workers from 4 depart-
ments of University College London (UCL). Measurements were 
obtained during three different sessions (one baseline session and 
two follow up sessions which were a few months apart) between 
November 2008 and June 2009. Three measurement cycles were 
obtained during each session. 
Each participant session consisted of a 15-minute interview followed 
by a respiratory evaluation conducted by a study researcher. The lat-
ter consisted of the measurement of exhaled air using an optical par-
ticle counter, Exhalair (model 102580-AK), produced by Pulmatrix 
Incorporated, which measured aerosol size and concentration 
by optical particle counting technology coupled with respiratory 
flow rate and volume measurements. Once written informed con-
sent was obtained, participants were asked to provide information 
regarding personal demographics, any chronic illnesses, prescribed 
medications, smoking status and any current symptoms of respira-
tory illness. Indoor and outdoor temperature and humidity readings 
were taken at the beginning of each session. The background aero-
sol count was recorded using a Lighthouse handheld 3013 Particle 
Counter, which measures the total number of particles greater than 
0.3 micrometres in diameter per 0.1 cubic foot of air (also referred 
to as atmospheric - aerosol particle count). 
Exhaled particle measurement 
Participants breathe with a normal tidal breathing pattern into a 
disposable mouthpiece whilst wearing a nose clip to prevent nose 
breathing. Valves direct exhaled breath into the optical particle 
counter. One-way valves and bacterial/viral High Efficiency Par-
ticulate Air (HEPA) filters prevent inhalation of infectious particles, 
ambient or upstream contaminants or previously exhaled breath. 
Both the one-way valve and inhalation filter are replaced for each 
individual. The exhaled breath passes by a laser diode, which 
counts and sizes the particles in the airstream. Prior to exhaust, the 
airstream is passed through an additional internal large capacity 
HEPA filter to remove any contaminating elements. 
Following initial calibration and a first washout period (which 
includes 3 deep breaths aimed at clearing any ambient particles 
from the respiratory tract), the Optical Particle Counter measures 
average size and concentration of exhaled particles in the range of 
0.3 to 20µm in diameter over the course of 15 tidal breaths. A visual 
display provides feedback to participants allowing them to regulate 
their breathing within standard tidal breathing limits (the software 
takes the average tidal wash-out period into account and applies the 
following additional criteria during the sampling interval for a breath 
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to be considered acceptable: peak inhale between 80–130% of 
average peak inhale and peak exhale between 80–139% of average 
peak exhale (with maximum exhale set at 28LPM). Minimum 
inhalation and exhalation volume = 60% of average inhalation and 
exhalation volumes respectively. This is due to the large variability 
in tidal volumes by a person so that they are held to being consistent 
from the tidal washout to the sampling interval. The process was 
repeated 3 times each session.
Statistical analysis
The dataset included 3 measurements per session for each partici-
pant, each representing the average number of particles per litre of 
exhaled breath over the course of 15 breaths. We plotted the particle 
count per litre during normal breathing at each attempt and each 
session for each individual included in the study. 
Given the right skewed distribution of submicron bio-aerosol 
count/L, we log transformed the data and assessed normality 
through kernel density plots. We explored whether specific indi-
vidual or environmental factors were associated with high particle 
production (i.e. ‘super-producers’), and defined high particle pro-
duction as any particle count equal to or above the 90th percentile 
of particle count among study participants. The explanatory vari-
ables considered were individual factors such as age, sex, ethnicity, 
height and weight, medical history and flu-like symptoms on the 
day measurements were taken, and environmental factors which 
were thought to affect particle production including season, indoor 
and outdoor temperature, humidity measurements and pollen count. 
Given that multiple measurements were obtained for the same indi-
viduals and that each individual was included in the study for one 
or more sessions at different periods in time, crude and adjusted 
odds ratios (ORs) for high particle production were obtained by 
multilevel logistic regression analysis. Multilevel analysis was 
required to take the hierarchical structure of the data into account 
and the non-independence of observations. Univariable models 
were initially built, and we considered all variables associated 
with the outcome at p<0.10 for multivariable analysis. The least 
significant factor was dropped from each model in a stepwise fash-
ion, until all variables remained significant at p<0.05. A sensitivity 
analysis was performed to explore how changes in the way super-
producers were defined impacted on the associations found, using 
varying thresholds between the 85th and 95th percentile to define 
superproducers. All analyses were performed in STATA (STATA 
12.0 IC, College Station, Texas, USA).
Respiratory/influenza like symptoms on the day of the measurement 
were defined as any two of the following symptoms: fever, sore 
throat, rhinitis or cough. 
We explored the stability of bio-aerosol production for individuals 
between measurements during each session as well as between each 
session. We did this for each pair of measurements within a session 
(e.g. measurement 1 and 2 in session 1) as well as between pairs 
of summary measurements between sessions (e.g. mean measure-
ment in sessions 1 and 2). We used Lin’s concordance correlation 
coefficient23, which is similar to a Pearson’s correlation coefficient 
for continuous variables, to assess the agreement between multiple 
continuous measurements on the same subject.
Results
Overall 79 individuals were included in this study, of which 56 (71%) 
were females (Table 1). The median age of the study participants 
was 32 years (range 22–62 years). More than half of them were 
researchers at UCL, and the rest were physicians, nurses, students, 
clerks and others (Table 1). Further information on the study partici-
pants can be found in Table 1. Thirty-seven individuals (47%) were 
followed up for a second session a few months later, and 13 (16%) 
Table 1. Characteristics of the 79 individuals included 
in the study.
Variables n %
Age 
20–29 31 39.24
30–39 24 30.38
40–49 15 18.99
50+ 9 11.39
Sex
Male 23 29.11
Female 56 70.89
Ethnicity
White British 53 71.62
White other 10 13.51
South Asian 5 6.76
Other Asian 2 2.7
Black African 4 5.41
Occupation
Nurse 2 2.53
Physician (medical) 5 6.33
Researcher 41 51.9
Clerical worker 16 20.25
Student 6 7.59
Other 9 11.39
Asthmatic
No 65 82.28
Yes 14 17.72
Body Mass Index (kg/m2)
underweight (<19.0) 3 3.8
normal (19.0–24.9) 45 56.96
overweight (25.0–29.9) 26 32.91
obese (30+) 5 6.33
Smoking status
never smoked 49 62.03
stopped >10yrs ago 5 6.33
stopped <10yrs ago 15 18.99
current smoker 10 12.66
Page 4 of 11
F1000Research 2013, 2:14 Last updated: 23 JAN 2014
were followed up twice (thus included in three different sessions), 
resulting in a total of 142 sessions. Of these, 50 (35%) were held 
during the summer, 12 (8%) were during autumn, 43 (30%) dur-
ing winter and another 37 (26%) during spring. Each individual 
completed a series of 3 cycles of measurements for each session 
attended, which resulted in a total of 426 measurements of breath-
ing cycles (59 of which were excluded due to incomplete data on 
particle size). 
The median total particle count per litre was 38.3 (range 3.3–1456 
particle count/L) with 99.9% of the total bio-aerosol production 
composed of particle sizes smaller than 1 micron and around 75% 
below 0.5 microns. Figure 1 shows the distribution of exhaled particle 
counts across all readings. The median sub-micron particle count 
was 37.3 counts/L (range 3.2–1456.4, 90th percentile 145.8/L).
Table 2 shows results of the logistic regression analysis of the asso-
ciation between a range of exploratory variables and high particle 
production (i.e. >90th percentile of particle production). We found 
an association with age, with proportionally more ‘super-producers’ 
in older age groups compared to younger ones. This association 
was not confounded by BMI, height, weight, sex or any other factor. 
There was no association between particle count and respiratory/
influenza-like symptoms at the time of measurement, including 
fever, dry and productive cough, runny nose, myalgia and headache 
(Table 2).
We also found a positive association with high tree pollen counts, 
which was not confounded by age hence the results in Table 2 are 
from the univariable analysis. We found no other environmental 
factor associated with high particle counts. Figure 2 shows the 
variation in pollen counts over the spring and summer study months.
The analysis with 85th and 95th centiles as the cut-off for defining 
super-producers yielded similar results and similar associations 
though point estimates and standard errors differed. Here we only 
present the results where the 90th centile was used as a cut-off to 
define super-producers.
We found that measurements repeated within a session were rela-
tively stable with good agreement between particle counts (con-
cordance coefficient rho ranging from 0.30 to 0.65, p-values <0.01) 
for all pairs of measurements within each session. However, we 
found little evidence that bio-aerosol production was stable over 
time, when comparing the geometric mean submicron particle 
counts/litre between each session (session 1 and 2: concordance 
coefficient rho 0.14 (95%CI -0.10, 0.38, p=0.238), session 1 and 3: 
rho 0.06 (95%CI -0.55–0.66, p=0.859), session 2 and 3: rho 0.36 
(95%CI -0.13–0.85, p=0.148)). Figure 3 shows a scatter plot com-
paring results from session one and session 2 demonstrating mini-
mal evidence of stability over time.
Exhaled particle production data
http://dx.doi.org/10.6084/m9.figshare.106632
Discussion
During tidal breathing, 99.9% of the total exhaled particle production 
consisted of particles measuring less than 1µm in diameter, which has 
Figure 1. Distribution of submicron particle count/L in exhaled air.
Figure 2. 5-day moving average of daily average pollen counts 
during the 2009 pollen season.
Figure 3. Stability of bio-aerosol production: scatterplot of mean 
submicron particle count per participant between sessions 1 and 2.
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Table 2. Results of the multilevel linear regression analysis on factors associated with log transformed 
submicron bio-aerosol count/L. * 2-sided Fisher’s exact test.
Variables n % super producers
Crude Odds 
Ratio (95% CI) p-value
Adjusted Odds 
Ratio (95% CI) p-value
Age
20–29 135 4.4 reference
30–39 117 9.4 2.61 (0.65–10.47) 0.175 2.45 (0.63–9.49) 0.196
40–49 78 19.2 6.47 (1.56–26.75) 0.010 6.33 (1.55–25.78) 0.010
50+ 42 14.3 4.19 (0.76–23.07) 0.099 4.96 (0.94–26.12) 0.059
Gender
Male 93 9.7 reference
Female 279 10.4 1.04 (0.29–3.74) 0.953
Asthma
No 316 11.1 reference
Yes 56 5.4 0.34 (0.07–2.17) 0.281
Body Mass Index (kg/m2)
underweight (<19.0) 18 22.2 reference
normal (19.0–24.9) 215 7.9 0.20 (0.01–1.59) 0.123
overweight (25.0–29.9) 111 13.5 0.39 (0.04–3.55) 0.401
obese (30+) 28 7.1 0.14 (0.00–2.81) 0.198
Smoking status
never smoked 240 10.0 reference
stopped >10yrs ago 25 24.0 4.66 (0.73–29.65) 0.103
stopped <10yrs ago 64 4.7 0.41 (0.08–2.21) 0.301
current smoker 40 7.5 0.73 (0.12–4.53) 0.738
Number of respiratory illnesses in the last year
0 52 5.8 reference
1 137 12.4 2.70 (0.43–16.81) 0.288
2 87 14.9 3.95 (0.56–27.78) 0.167
3 41 4.9 0.81 (0.07–9.78) 0.865
4 55 5.4 0.82 (0.08–8.72) 0.872
Respiratory/Influenza-like symptoms at the time of measurement
Yes 37 0
No 335 11.3 NA 0.022*
Indoor temperature (degrees Celsius)
<21.5 85 5.9 reference
21.5–23.2 110 12.7 2.67 (0.57–16.78) 0.19
23.3–24.4 81 11.1 2.63 (0.45–17.57) 0.267
24.5+ 96 10.4 2.05 (0.39–13.36) 0.364
Outdoor temperature (degrees Celsius)
<6.3 98 4.1 reference reference
6.3–17.6 92 4.3 1.05 (0.18–6.24) 0.955 1.12 (0.21–5.96) 0.893
17.7–23.7 92 18.4 7.92 (1.68–37.13) 0.009 6.56 (1.56–27.49) 0.01
23.8+ 90 14.4 5.11 (1.08–24.18) 0.039 5.88 (1.31–26.41) 0.021
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Variables n % super producers
Crude Odds 
Ratio (95% CI) p-value
Adjusted Odds 
Ratio (95% CI) p-value
Indoor humidity (%)
<30.0 86 19.8 reference
30.0–34.9 117 6.8 0.21 (0.05–0.86) 0.03
35.0–39.9 80 3.7 0.10 (0.01–0.62) 0.013
40.0+ 89 11.2 0.41 (0.10–1.65) 0.21
Outdoor humidity (%)
<31.0 96 13.5 reference
31.0–34.4 83 9.6 0.49 (0.14–2.89) 0.548
34.5–37.9 94 6.4 0.29 (0.72–1.76) 0.207
38+ 99 11.1 0.52 (0.16–2.95) 0.621
Season
Summer 136
7.3 reference referenceAutumn 30
Winter 110
Spring 96 18.2 4.38 (1.32–14.56) 0.016 4.44 (1.45–13.57) 0.09
High tree pollen count
No 54
Yes 318 6.25 (1.58–24.64) 0.009 5.66 (1.62–19.72) 0.006
High grass pollen count
No 56
Yes 316 0.69 (0.12–3.88) 0.674
High nettle pollen count
No 279
Yes 93  0.70 (0.18–2.73) 0.603   
Note: Due to collinearity, tree pollen count, spring season and outdoor temperature were adjusted for age separately. Age in table 
is adjusted for pollen count.
confirmed findings from previous studies4,8,9. In common with other 
studies, we observed high variability in the levels of exhaled particle 
production between individuals3,24,27. Unlike previous studies we were 
also able to assess stability over time and found that measurements 
taken several months apart were not well correlated. The size of our 
study enabled us to assess a range of putative predictors of exhaled 
particle production, including age, gender, height and weight, smoking 
history, chronic respiratory disease and acute respiratory symptoms. 
We found that high particle production was associated with older age, 
but not with any other individual factor, and also observed an ecological 
association between high particle production and high pollen count. 
The predominance of sub-micron particles in exhaled breath under-
lines the potential importance of airborne transmission in respiratory 
infection. The high level of variation in particle production between 
individuals may account for the observed heterogeneity in transmis-
sion of respiratory infection21. The lack of stability of particle counts 
over time, however, suggests that individuals with high particle 
counts who may be more infectious during one episode of infection 
may not be as infectious during subsequent episodes of infection. 
The association with age suggests an age related deterioration of the 
respiratory system22,25 through decreased elasticity, lower levels of 
surfactant, age-associated increases in airways closure26 or increased 
likelihood of chronic inflammation, which may influence production 
of exhaled particles. There is no evidence from the literature, however, 
that older adults are more likely to transmit respiratory infections 
compared with younger adults. The association with pollen counts 
also suggests that airway irritation may increase the production of 
exhaled particles. 
This is the largest study to date of exhaled particle production in 
healthy volunteers and the first to assess the stability of the population 
in a subset of participants. We did not attempt to gain a representative 
sample of the population, rather relying on recruiting colleagues who 
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were more easily accessible. This potentially limits generalizability. 
No children or adults of post-retirement age were included, limiting 
the conclusions that can be made about age-related trends. Finally, 
since the hypothesis of an association with high pollen counts was 
developed post hoc following observations that particle counts 
tended to be higher in spring and summer months, this association 
should be treated with caution. The association is also ecological, 
and therefore potentially confounded by other variables not cap-
tured here. It is important that future studies of variation in produc-
tion assess this over a wider age range, incorporate measures of 
stability and assess the impact of potential environmental factors 
on production. 
Finally, this study was conducted among healthy volunteers. Whilst 
a small proportion of these “healthy” volunteers had mild respira-
tory symptoms at the time of measurement, the study was not de-
signed to assess the impact of respiratory infections or other acute 
or chronic respiratory problems on exhaled particle production. It 
may be that particle production in individuals will change through 
the course of respiratory infections affecting transmission.
A better understanding of the role of airborne transmission in 
the spread of infections is critical to informing disease transmis-
sion models and control policy. For example in influenza, a high 
risk from airborne transmission may influence decisions about 
appropriate levels of social distancing, use of respirators rather than 
surgical masks and appropriate isolation facilities for patients with 
newly emergent strains28. Further studies focussing on measure-
ments during the course of acute respiratory infections are needed 
to investigate infection-induced changes in particle production. 
In addition, studies are needed to explore whether variations in 
exhaled particle production are associated with an increased res-
piratory infection transmission risk. Given the lack of stability of 
production over time it will be important that such studies measure 
particle production and transmission risk over the same time period. 
Such studies are fundamental to our understanding of respiratory 
infection transmission.
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